Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation

Non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation is sensitive to EGFR tyrosine kinase inhibitors (TKIs). But little is known about the response to EGFR TKIs and the prognostic role of compound mutations. This study compared the uncommon EGFR exon 21 L858R compound mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liang, Song, Zhigang, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410901/
https://www.ncbi.nlm.nih.gov/pubmed/25960661
http://dx.doi.org/10.2147/OTT.S78984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410901/
https://www.ncbi.nlm.nih.gov/pubmed/25960661
http://dx.doi.org/10.2147/OTT.S78984

Ejemplares similares